Literature DB >> 3018803

The role of beta-lactamase inhibitors in chemotherapy.

H C Neu.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3018803     DOI： 10.1016/0163-7258(85)90044-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  3 in total

1.  In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.

Authors:  R J Fass; W W Gregory; R F D'Amato; J M Matsen; D N Wright; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.

Authors:  C C Sanders; J P Iaconis; G P Bodey; G Samonis
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

3.  Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD).

Authors:  J H Sportel; G H Koëter; R van Altena; A Löwenberg; W G Boersma
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.